The guidelines for colorectal screening were recently revised. Please join us for Colorectal Cancer Screening and Colon Polyp Surveillance: An Updated Guidelines-Based Approach with Dr. Jodie A. Barkin. Dr. Barkin will discuss different types of colorectal cancer screening modalities and updated intervals for surveillance for history of colon polyps
Internal Medicine Physicians, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, Pharmacists and all other interested healthcare providers
- Discuss different types of colorectal cancer screening modalities.
- Identify the evidence for starting colorectal cancer screening in average-risk patients at age 45, and recognize when to begin screening in patients with family history.
- Appreciate the data and factors that affect decisions on colorectal cancer screening in patients aged 76-85.
- Explain the rationale for stopping colorectal cancer screening after age 85.
- Discuss updated intervals for surveillance for history of colon polyps.
FACULTY AND DISCLOSURES:
Jodie A. Barkin, M.D.
Associate Professor of Clinical Medicine
Department of Medicine, Division of Digestive Health and Liver Diseases
University of Miami, Leonard M. Miller School of Medicine
Jodie A. Barkin, M.D., indicated that he is a scientific advisor for AbbVie, Nestle Health Sciences, CorEvitas LLC, Envara Health, Medtronic. Dr. Barkin is involved with the career development grant for Cystic Fibrosis Foundation DIGEST Grant. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.
John Rubin, M.D., director for this educational event, owns stock in AstraZeneca and Bristol Myers Squibb. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.
Kenneth Rosenthal, M.D., FACG, moderator for this educational event, indicated that he is on the Speaker’s Bureau for AbbVie, Inc. All of the relevant financial relationships listed for this individual has been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer
ACCREDITATION STATEMENTS AND CREDITS
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-855841, by the Florida Boards of Medicine, Podiatry, Dentistry, Osteopathic Medicine and Physician Assistants.
This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Florida Board of Athletic Training
- 1.00 General certificate of attendance
- 1.00 Florida Board of Dentistry
- 1.00 Florida Board of Dietitians
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy